Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.57 |
| ▸ | HPGD | P15428 | 7/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | NFE2L2 | Q16236 | 2/20 | 0.57 |
| ▸ | TFEB | P19484 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | LMNA | P02545 | 3/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | RAB9A | P51151 | 2/20 | 0.51 |
| ▸ | BCHE | P06276 | 1/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.51 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.51 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.50 |
| ▸ | LY96 | Q9Y6Y9 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19244449 | 0.84 | KDM4E (0.63) | KDM4EHPGDALDH1A1L3MBTL1NFE2L2 | |
| SCHEMBL19244450 | 0.84 | KDM4E (0.63) | KDM4EHPGDALDH1A1L3MBTL1NFE2L2 | |
| SCHEMBL19244299 | 0.83 | NFE2L2 (0.66) | KDM4EHPGDALDH1A1L3MBTL1NFE2L2 | |
| SCHEMBL15836 | 0.83 | NFE2L2 (0.66) | KDM4EHPGDALDH1A1L3MBTL1NFE2L2 | |
| Propionic Acid SCHEMBL28155113 | 0.82 | NFE2L2 (0.57) | KDM4EHPGDALDH1A1L3MBTL1NFE2L2 | |
| SCHEMBL15188 | 0.80 | KDM4E (0.67) | KDM4EHPGDALDH1A1NFE2L2TFEB | |
| SCHEMBL4775241 | 0.80 | KDM4E (0.67) | KDM4EHPGDALDH1A1NFE2L2TFEB | |
| SCHEMBL31506312 | 0.80 | KDM4E (0.67) | KDM4EHPGDALDH1A1NFE2L2TFEB | |
| SCHEMBL13957562 | 0.80 | KDM4E (0.67) | KDM4EHPGDALDH1A1NFE2L2TFEB | |
| SCHEMBL31419776 | 0.80 | SMN1; SMN2 (0.54) | KDM4EHPGDALDH1A1L3MBTL1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 431 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10555892-B1 | Functionalized siloxane or polysiloxane coated particles with enhanced light filtering properties | NANOPHASE TECHNOLOGIES CORPORATION (US) | 2020-02-11 | — | — | US | claimed |
| US-20150174045-A1 | LIGHT PROTECTING COMPOSITION WITH REDUCED TOTAL AMOUNT OF UV FILTER CONTAINING A POLYSILOXANE-BASED UV FILTER | DSM IP ASSETS B.V. (NL) | 2015-06-25 | — | — | US | claimed |
| WO-2013102248-A2 | \"AQUEOUS COSMETIC SUNSCREEN COMPOSITION AND USE THEREOF, COSMETIC METHOD FOR APPLICATION OF SAID COMPOSITION, COSMETIC METHOD TO PREVENT AND CONTROL SKIN OILINESS, COSMETIC METHOD TO PROTECT THE SKIN FROM THE DAMAGES CAUSED BY ULTRAVIOLET RADIATION, AND COSMETIC PRODUCT.\ | . JOHNSON & JOHNSON DO BRASIL INDUSTRIA E COMERCIO DE PRODUTOS PARA SAUDE LTDA. (BR) | 2013-07-11 | — | — | WO | claimed |
| EP-1899015-B1 | COMPOSITION WITH TIGHT CAPSULES CONTAINING A SUNSCREEN AGENT | DSM IP ASSETS BV (NL) | 2012-03-21 | — | — | EP | claimed |
| WO-2009129855-A1 | PHOTOPROTECTIVE COMPOSITIONS CONTAINING PEPTIDES | UNITED TECHNOLOGIES UT AG (CH) | 2009-10-29 | — | — | WO | claimed |
| US-20080199526-A1 | Composition With Tight Capsules Containing a Sunscreen Agent | DSM IP ASSETS B.V. (NL) | 2008-08-21 | — | — | US | claimed |
| EP-1899015-A1 | COMPOSITION WITH TIGHT CAPSULES CONTAINING A SUNSCREEN AGENT | DSMIP Assets B.V. (NL) | 2008-03-19 | — | — | EP | claimed |
| WO-2007000316-A1 | COMPOSITION WITH TIGHT CAPSULES CONTAINING A SUNSCREEN AGENT | DSM IP ASSETS B.V. (NL) | 2007-01-04 | — | — | WO | claimed |
| WO-2026087156-A1 | PERSONAL CARE COMPOSITION | UNILEVER IP HOLDINGS B.V. (NL) | 2026-04-30 | — | — | WO | disclosed |
| US-12582587-B2 | Sunscreen composition and methods of protection from ultraviolet and visible light | DOC MARTIN'S OF MAUI (US) | 2026-03-24 | — | — | US | disclosed |
| EP-4665297-A1 | A COSMETIC COMPOSITION | Unilever IP Holdings B.V. (NL) | 2025-12-24 | — | — | EP | disclosed |
| US-12409115-B2 | Sunscreen composition comprising visible light protecting agents and methods of use | DOC MARTIN'S OF MAUI (US) | 2025-09-09 | — | — | US | disclosed |
| EP-3471694-B1 | SUNSCREEN COMPOSITIONS CONTAINING A COMBINATION OF A LINEAR ULTRAVIOLET RADIATION-ABSORBING POLYETHER AND OTHER ULTRAVIOLET-SCREENING COMPOUNDS | KENVUE BRANDS LLC (US) | 2025-07-02 | — | — | EP | disclosed |
| CN-120201986-A | Sun-proof cosmetic | 株式会社高丝 | 2025-06-24 | — | — | CN | disclosed |
| EP-0998906-A2 | Shampoo composition | F. HOFFMANN-LA ROCHE AG (CH) | 2000-05-10 | — | — | EP | disclosed |
| EP-0979645-A1 | Light screening composition containing a polysiloxane type UV-B screening agent and a benzimidazol type UV-B screening agent | F. HOFFMANN-LA ROCHE AG (CH) | 2000-02-16 | — | — | EP | disclosed |
| US-6018044-A | TRIS((ALKYL, SILANE, OLIGOSILOXANE OR POLYSILOXANE)(OXY OR AMINO)CARBONYL-(1,4-PHENYLENE)-AMINO)-S-TRIAZINES HAVING AT LEAST ONE SILICON CONTAINING MOIETY OF GIVEN FORMULA; USE AS UV-B FILTERS IN LIGHT SCREENING COMPOSITIONS | ROCHE VITAMINS INC. (US) | 2000-01-25 | — | — | US | disclosed |
| US-5985251-A | DIBENZOYLMETHANE DERIVATIVE, 3,3-DIPHENYLACRYLATE- OR BENZYLIDENE CAMPHOR DERIVATIVE, P-METHOXYCINNAMATE DERIVATIVE, | ROCHE VITAMINS INC. (US) | 1999-11-16 | — | — | US | disclosed |
| EP-0933376-A2 | Silanyl-triazines as light screening compositions | F. HOFFMANN-LA ROCHE AG (CH) | 1999-08-04 | — | — | EP | disclosed |
| EP-0920858-A2 | Light screening composition | F. HOFFMANN-LA ROCHE AG (CH) | 1999-06-09 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10555892-B1 | Functionalized siloxane or polysiloxane coated particles with enhanced light filtering properties | SPIN4, RPS4X, RPS4Y1 | KDM4E 1042/4885HPGD 4771/4885ALDH1A1 3150/4885 |
| US-12582587-B2 | Sunscreen composition and methods of protection from ultraviolet and visible light | SOD1, TYR, SLC40A1 | KDM4E 3241/4885HPGD 1381/4885ALDH1A1 645/4885 |
| US-20080199526-A1 | Composition With Tight Capsules Containing a Sunscreen Agent | SUN2, DSG1, DSC1 | KDM4E 604/4885HPGD 808/4885ALDH1A1 258/4885 |
| US-20150174045-A1 | LIGHT PROTECTING COMPOSITION WITH REDUCED TOTAL AMOUNT OF UV FILTER CONTAINING A POLYSILOXANE-BASED UV FILTER | ERCC4, ERCC2, ERCC1 | KDM4E 2251/4885HPGD 1636/4885ALDH1A1 2214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.